ASX - Delayed Quote AUD

Australian Clinical Labs Limited (ACL.AX)

3.1600

+0.0600

+(1.94%)

As of 3:20:26 PM GMT+10. Market Open.

Australian Clinical Labs Limited (ASX:ACL) is a favorite amongst institutional investors who own 62%

Key Insights Significantly high institutional ownership implies Australian Clinical Labs' stock price is sensitive to...

Simply Wall St. last month

ACL.AX
+1.94%
Australian Clinical Labs First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags

Australian Clinical Labs ( ASX:ACL ) First Half 2025 Results Key Financial Results Revenue: AU$369.2m (up 9.5% from 1H...

Simply Wall St. 2 months ago

ACL.AX
+1.94%
Australian Clinical Labs' (ASX:ACL) Dividend Will Be A$0.035

Australian Clinical Labs Limited's ( ASX:ACL ) investors are due to receive a payment of A$0.035 per share on 16th of...

Simply Wall St. 2 months ago

ACL.AX
+1.94%
Has Australian Clinical Labs Limited's (ASX:ACL) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Most readers would already be aware that Australian Clinical Labs' (ASX:ACL) stock increased significantly by 11% over...

Simply Wall St. 2 months ago

ACL.AX
+1.94%
An Intrinsic Calculation For Australian Clinical Labs Limited (ASX:ACL) Suggests It's 40% Undervalued

Key Insights Australian Clinical Labs' estimated fair value is AU$6.04 based on 2 Stage Free Cash Flow to Equity...

Simply Wall St. 4 months ago

ACL.AX
+1.94%
With 60% institutional ownership, Australian Clinical Labs Limited (ASX:ACL) is a favorite amongst the big guns

Key Insights Significantly high institutional ownership implies Australian Clinical Labs' stock price is sensitive to...

Simply Wall St. 6 months ago

ACL.AX
+1.94%
Why Australian Clinical Labs Limited (ASX:ACL) Could Be Worth Watching

Australian Clinical Labs Limited ( ASX:ACL ), might not be a large cap stock, but it received a lot of attention from a...

Simply Wall St. 7 months ago

ACL.AX
+1.94%
We Wouldn't Be Too Quick To Buy Australian Clinical Labs Limited (ASX:ACL) Before It Goes Ex-Dividend

Australian Clinical Labs Limited ( ASX:ACL ) stock is about to trade ex-dividend in 3 days. The ex-dividend date is one...

Simply Wall St. 7 months ago

ACL.AX
+1.94%
Australian Clinical Labs Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Australian Clinical Labs ( ASX:ACL ) Full Year 2024 Results Key Financial Results Revenue: AU$697.5m (flat on FY 2023...

Simply Wall St. 8 months ago

ACL.AX
+1.94%
Do Its Financials Have Any Role To Play In Driving Australian Clinical Labs Limited's (ASX:ACL) Stock Up Recently?

Australian Clinical Labs (ASX:ACL) has had a great run on the share market with its stock up by a significant 30% over...

Simply Wall St. 8 months ago

ACL.AX
+1.94%
Top ASX Stocks Estimated To Be Undervalued In July 2024

The Australian stock market has shown robust growth, climbing 3.1% over the past week and achieving a 10% increase over the last year, with earnings expected to grow by 13% annually. In this context, identifying stocks that are potentially undervalued could offer investors an opportunity to capitalize on this positive momentum.

Simply Wall St. 9 months ago

IPG.AX

PWRHF

ACL.AX
+1.94%
Top ASX Stocks Estimated as Undervalued for Investment Opportunities in July 2024

As the Australian market navigates through varied sector performances with the ASX200 recently closing down slightly, opportunities for investment can emerge from analyzing undervalued stocks. Given current conditions, such as the recovery in iron ore prices and specific sector movements, identifying stocks that are priced below their intrinsic value could offer potential growth prospects for investors.

Simply Wall St. 9 months ago

PWRHF

ACL.AX
+1.94%

IPG.AX
Australian Clinical Labs Limited's (ASX:ACL) Intrinsic Value Is Potentially 85% Above Its Share Price

Key Insights Using the 2 Stage Free Cash Flow to Equity, Australian Clinical Labs fair value estimate is AU$4.65...

Simply Wall St. 9 months ago

ACL.AX
+1.94%

Performance Overview

Return	ACL.AX	S&P/ASX 200 [XJO] (^AXJO)
YTD	-7.07%	+0.03%
1-Year	+33.63%	+6.24%
3-Year	-25.48%	+13.27%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Australian Clinical Labs Limited (ACL.AX)

Australian Clinical Labs Limited (ASX:ACL) is a favorite amongst institutional investors who own 62%

Australian Clinical Labs First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags

Australian Clinical Labs' (ASX:ACL) Dividend Will Be A$0.035

Has Australian Clinical Labs Limited's (ASX:ACL) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

An Intrinsic Calculation For Australian Clinical Labs Limited (ASX:ACL) Suggests It's 40% Undervalued

With 60% institutional ownership, Australian Clinical Labs Limited (ASX:ACL) is a favorite amongst the big guns

Why Australian Clinical Labs Limited (ASX:ACL) Could Be Worth Watching

We Wouldn't Be Too Quick To Buy Australian Clinical Labs Limited (ASX:ACL) Before It Goes Ex-Dividend

Australian Clinical Labs Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Do Its Financials Have Any Role To Play In Driving Australian Clinical Labs Limited's (ASX:ACL) Stock Up Recently?

Top ASX Stocks Estimated To Be Undervalued In July 2024

Top ASX Stocks Estimated as Undervalued for Investment Opportunities in July 2024

Australian Clinical Labs Limited's (ASX:ACL) Intrinsic Value Is Potentially 85% Above Its Share Price

Performance Overview